Relationship between processes of care and coronary bypass operative mortality and morbidity

被引:16
作者
O'Brien, MM
Shroyer, ALW
Moritz, TE
London, MJ
Grunwald, GK
Villanueva, CB
Thottapurathu, LG
MaWhinney, S
Marshall, G
McCarthy, M
Henderson, WG
Sethi, GK
Grover, FL
Hammermeister, KE
机构
[1] Denver VA Med Ctr, Cardiol Sect, Denver, CO 80220 USA
[2] Denver VA Med Ctr, Med Res Serv, Denver, CO 80220 USA
[3] Denver VA Med Ctr, Surg Serv, Denver, CO 80220 USA
[4] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Cooperat Studies Program Coordinating Ctr, Hines, IL 60141 USA
[5] San Francisco VA Med Ctr, Anesthesiol Serv, San Francisco, CA USA
[6] Univ Calif San Francisco, Dept Anesthesiol, San Francisco, CA 94143 USA
[7] Univ Colorado, Hlth Sci Ctr, Dept Med, Boulder, CO 80309 USA
[8] Univ Colorado, Hlth Sci Ctr, Dept Surg, Boulder, CO 80309 USA
[9] Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Boulder, CO 80309 USA
[10] Univ Colorado, Hlth Sci Ctr, Colorado Hlth Outcomes Program, Boulder, CO 80309 USA
[11] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
[12] Univ Arizona, Hlth Sci Ctr, Dept Surg, Tucson, AZ 85721 USA
[13] Pontificia Univ Catolica Chile, Dept Salud Publ, Santiago, Chile
关键词
coronary bypass surgery; processes of care; perioperative mortality and morbidity; operative duration; inotropic agents; transesophageal echocardiography; hemoconcentration/ultrafiltration;
D O I
10.1097/01.mlr.0000102295.08379.57
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Information is limited regarding the effects of processes of care on cardiac surgical outcomes. Correspondingly, many recommended cardiac surgical processes of care are derived from animal experiments or clinical judgment. This report from the VA Cooperative Study in Health Services, "Processes, Structures, and Outcomes of Cardiac, Surgery," focuses on the relationships between 3 process groups (preoperative evaluation, intraoperative care, and supervision by senior physicians) and a composite outcome, perioperative mortality and morbidity. Methods: Data on 734 risk, process, and structure variables were collected prospectively on 3988 patients who underwent coronary artery bypass grafting at 14 VA medical centers between 1992 and 1996. Data reduction was accomplished by examining data completeness and variation across sites and surgeon, using previously published data and clinical judgment., We then applied multivariable logistic regression to the 39 remaining processes of care to determine which were related to the composite outcome after adjusting for 17 patient-related risk factors and controlling for intraoperative complications. Results: Our first analysis showed several measures of operative duration, the use of inotropic agents, transesophageal echo, lowest systemic temperature, and hemoconcentration/ultrafiltration, to be powerful predictors of the composite outcome. Because the use of inotropic agents and operative duration may be related to an intermediate outcome (eg, intraoperative complications), we performed a second analysis omitting the se processes. The use of intraoperative transesophageal echo and hemoconcentration/ultrafiltration remained significantly associated with an increased risk of an event (odds ratios 1.60 and 1.36, respectively). Conclusions: Our results viewed in the context of past studies suggest the possibility that, inotropic use, TEE, and hemoconcentration/ultrafiltration may have adverse effects on operative outcome. Further evaluation of these processes of care using observational data, as well as randomized trials when feasible, would be of interest.
引用
收藏
页码:59 / 70
页数:12
相关论文
共 63 条
[1]   NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].
AKAIKE, H .
IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723
[2]   Development and analysis of a new certifying examination in perioperative transesophageal echocardiography [J].
Aronson, S ;
Butler, A ;
Subhiyah, R ;
Buckingham, RE ;
Cahalan, MK ;
Konstandt, S ;
Mark, J ;
Ramsay, J ;
Savage, R ;
Savino, J ;
Shanewise, JS ;
Smith, J ;
Thys, D .
ANESTHESIA AND ANALGESIA, 2002, 95 (06) :1476-1482
[3]   Update on recent clinical trials in congestive heart failure [J].
Betkowski, AS ;
Hauptman, PJ .
CURRENT OPINION IN CARDIOLOGY, 2000, 15 (04) :293-303
[4]   Transesophageal echocardiography: Not an innocuous procedure [J].
Brinkman, WT ;
Shanewise, JS ;
Clements, SD ;
Mansour, KA .
ANNALS OF THORACIC SURGERY, 2001, 72 (05) :1725-1726
[5]  
BUCK SF, 1960, J ROY STAT SOC B, V22, P302
[6]   Pharmacologic treatment of congestive heart failure [J].
Carson, P .
CLINICAL CARDIOLOGY, 1996, 19 (04) :271-277
[7]  
CHO T, 1987, ACTA PATHOL JAPON, V37, P123
[8]   Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support [J].
Cimochowski, GE ;
Harostock, MD ;
Foldes, PJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (04) :655-666
[9]  
Crombie I K, 1998, J Eval Clin Pract, V4, P31, DOI 10.1046/j.1365-2753.1998.t01-1-00003.x
[10]  
De Ritis G, 1995, Minerva Anestesiol, V61, P173